Article
Emergence and spread of Plasmodium falciparum PX1 polymorphisms associated with decreased susceptibility to antimalarials in Uganda.
Nature medicine - 1 Sept 2026
Niaré Karamoko, Tafesse Bersabeh, Treat Mayland, Sadler Jacob M, Okitwi Martin, Orena Stephen, Asua Victor, Kreutzfeld Oriana, Legac Jenny, Marglous Jacob, Nsobya Samuel L, Yeka Adoke, Richard Dave, Ferdig Michael T, Mukherjee Angana, Rosenthal Philip J, Juliano Jonathan J, Bailey Jeffrey A, Conrad Melissa D
Abstract excerpt
Artemisinin-based combination therapies are the cornerstone of malaria treatment and control. In Africa, artemether-lumefantrine is the most widely used first-line artemisinin-based combination therapy, but its efficacy in Uganda is increasingly threatened by the emergence of artemisinin partial resistance and reduced lumefantrine susceptibility. To identify loci contributing to this decreased susceptibility,...
Read the complete abstract on PubMedTopics
- Plasmodium falciparum
- Uganda
- Humans
- Antimalarials
- Drug Resistance
